GEORGE P. CHROUSOS, M.D.; THOMAS H. SCHUERMEYER, M.D.; JOHN DOPPMAN, M.D.; EDWARD H. OLDFIELD, M.D.; HEINRICH M. SCHULTE, M.D.; PHILIP W. GOLD, M.D.; D. LYNN LORIAUX, M.D., Ph.D.
Ovine and human corticotropin-releasing factors (CRF) have similar potencies in causing adrenocorticotropic hormone (ACTH) and cortisol secretion in normal humans. Using long-acting ovine CRF (1 µg/kg body weight as an intravenous bolus), we tested patients with Cushing's syndrome, adrenal insufficiency, and psychiatric conditions with mild hypercortisolism. Over 95% of hypercortisolemic patients with a pituitary adenoma responded with increases in plasma ACTH and cortisol concentrations; patients with the ectopic ACTH syndrome had no ACTH or cortisol responses; patients with ACTH-independent hypercortisolism of adrenal origin had low or undetectable plasma ACTH concentrations before and after CRF without any cortisol response. The differences in responses of patients with adrenal insufficiency of primary, pituitary, or suprapituitary type likewise suggest value of the CFR test in their differential diagnosis. The responses in the psychiatric patients should permit differentiation between Cushing's syndrome and hypercortisolism of psychiatric origin.
Learn more about subscription options.
Register Now for a free account.
CHROUSOS GP, SCHUERMEYER TH, DOPPMAN J, OLDFIELD EH, SCHULTE HM, GOLD PW, et al. Clinical Applications of Corticotropin-Releasing Factor. Ann Intern Med. 1985;102:344–358. doi: 10.7326/0003-4819-102-3-344
Download citation file:
Published: Ann Intern Med. 1985;102(3):344-358.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only